Small Cap
Medical Instruments & Supplies
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
BioLife Solutions
BLFS
$1.82B
| $1.82B | $37.22 | 0.08% |
|
2
LeMaitre Vascular
LMAT
$1.81B
| $1.81B | $78.97 | 1.24% |
|
|
KMTS
3
Kestra Medical Technologies
KMTS
$1.58B
| $1.58B | $26.92 | 0.04% |
|
4
Azenta
AZTA
$1.45B
| $1.45B | $33.21 | 1% |
|
5
STAAR Surgical
STAA
$1.16B
| $1.16B | $23.18 | 0.34% |
|
|
AVR
6
Anteris Technologies
AVR
$866M
| $866M | $8.89 | 1.02% |
|
7
AngioDynamics
ANGO
$659M
| $659M | $15.95 | 1.14% |
|
8
Perspective Therapeutics
CATX
$376M
| $376M | $3.29 | 3.13% |
|
|
NNNN
9
Anbio Biotechnology
NNNN
$344M
| $344M | $7.83 | 0.89% |
|
10
Sanara MedTech
SMTI
$319M
| $319M | $34.67 | 0.84% |
|
11
Embecta
EMBC
$285M
| $285M | $5.03 | 0.8% |
|
12
OraSure Technologies
OSUR
$261M
| $261M | $3.78 | 1.05% |
|
Small Cap Medical Instruments & Supplies Stocks at a Glance
Medical instruments and supplies companies make the consumables and tools of daily care — syringes, catheters, surgical instruments, dental equipment, and eyewear. Recurring, procedure-driven demand makes the group defensive, with razor-and-blade consumable models supporting stable margins.
There are 12 small cap Medical Instruments & Supplies stocks — companies in the Medical Instruments & Supplies industry with a market cap between $250M and $2B — worth a combined $10.9B.
The largest by market cap are BioLife Solutions (BLFS) at $1.82B, LeMaitre Vascular (LMAT) at $1.81B and Kestra Medical Technologies (KMTS) at $1.58B.
Among institutional investors, BioLife Solutions (BLFS) drew the most net new fund positions in Q2 2026: 57 funds opened new positions, taking total fund holders up 29 (16%) quarter-over-quarter.
- Combined market cap: $10.9B across 12 stocks.
- Small Cap: market cap between $250M and $2B.
- Largest constituent: BioLife Solutions (BLFS), $1.82B market cap.
- Most net new fund positions in Q2 2026: BioLife Solutions (BLFS), +29 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.